中国同种异体造血干细胞移植:2014年最新进展

Clinical transplants Pub Date : 2014-01-01

Meng Lv, Xiao-Jun Huang

{"title":"中国同种异体造血干细胞移植:2014年最新进展","authors":"Meng Lv, Xiao-Jun Huang","doi":"","DOIUrl":null,"url":null,"abstract":"Allogeneic hematopoietic stem cell transplantation (allo-HSCT) provides powerful curative weapons for patients with certain hematological diseases. Great improvements have been made within recent years, particularly in the fields of haploidentical HSCT, allo-HSCT for aplastic anemia, and strategies to overcome relapse and graft versus host disease. This review updates the current state of allo-HSCT in China.","PeriodicalId":77074,"journal":{"name":"Clinical transplants","volume":" ","pages":"235-44"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Allo-Hematopoietic Stem Cell Transplant in China: 2014 Update.\",\"authors\":\"Meng Lv, Xiao-Jun Huang\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Allogeneic hematopoietic stem cell transplantation (allo-HSCT) provides powerful curative weapons for patients with certain hematological diseases. Great improvements have been made within recent years, particularly in the fields of haploidentical HSCT, allo-HSCT for aplastic anemia, and strategies to overcome relapse and graft versus host disease. This review updates the current state of allo-HSCT in China.\",\"PeriodicalId\":77074,\"journal\":{\"name\":\"Clinical transplants\",\"volume\":\" \",\"pages\":\"235-44\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical transplants\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical transplants","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

同种异体造血干细胞移植(Allogeneic hematopoietic stem cell transplantation, alloo - hsct)为某些血液病患者提供了强有力的治疗武器。近年来，特别是在单倍体造血干细胞移植、治疗再生障碍性贫血的同种异体造血干细胞移植以及克服复发和移植物抗宿主病的策略方面取得了很大的进展。这篇综述更新了中国同种异体造血干细胞移植的现状。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Allo-Hematopoietic Stem Cell Transplant in China: 2014 Update.

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) provides powerful curative weapons for patients with certain hematological diseases. Great improvements have been made within recent years, particularly in the fields of haploidentical HSCT, allo-HSCT for aplastic anemia, and strategies to overcome relapse and graft versus host disease. This review updates the current state of allo-HSCT in China.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical transplants

自引率

0.00%

发文量